NO big deal: Two types of pulmonary hypertension respond to novel agent

Functional capacity and right-ventricular function improved on treatment with an investigational oral agent that stimulates soluble guanylate cyclase in nitric-oxide biochemical pathways. But don't mix the drug with PDE-5 inhibitors or nitrates, say researchers.
Source: theHeart.org - Category: Cardiology Source Type: news